Net Asset Value(s)

Click here - to use the wp menu builder

News Room

Less than 1 min.Read

Net Asset Value(s)

By Investing Today

January 9, 2025

Octopus AIM VCT 2 plc

Net Asset Value

Octopus AIM VCT 2 plc announces that as at 31 December 2024 the unaudited net asset value of the Ordinary shares was approximately 40.7 pence per share.

For further information, please contact:

Rachel Peat
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Uniti Group Inc. Announces Launch of Fiber Securitization Notes Offering

Net Asset Value(s)

New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis

Ress Life Investments A/S publishes financial calendar

Form 8.5 (EPT/RI) – Dowlais Group plc

Form 8.5 (EPT/RI) – Thruvision Group plc

Form 8.5 (EPT/RI) – De La Rue plc

Topics

New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis

Ress Life Investments A/S publishes financial calendar

Form 8.5 (EPT/RI) – Dowlais Group plc

Form 8.5 (EPT/RI) – Thruvision Group plc

Form 8.5 (EPT/RI) – De La Rue plc

Form 8.5 (EPT/RI)-Alliance Pharma plc

Stellantis and Mistral AI Strengthen Strategic Partnership to Enhance Customer Experience, Vehicle Development and Manufacturing

Municipality Finance issues a GBP 25 million tap under its MTN programme

Related Articles

New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis

Ress Life Investments A/S publishes financial calendar

Form 8.5 (EPT/RI) – Dowlais Group plc

Form 8.5 (EPT/RI) – Thruvision Group plc

Form 8.5 (EPT/RI) – De La Rue plc

Company

Headlines

New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis

Ress Life Investments A/S publishes financial calendar

Form 8.5 (EPT/RI) – Dowlais Group plc

Form 8.5 (EPT/RI) – Thruvision Group plc

Newsletter